Skip to content
Search

Latest Stories

Submit Guest Post

Vedanta Ltd’s capital expenditure touches £1.17bn in 2019

INDIAN business tycoon Anil Agarwal led Vedanta Ltd said that it spent Rs 100 billion (£1.17bn) on capital expenditure programme in the financial year 2019.

Speaking at the annual general meeting of Vedanta Ltd in New Delhi, company’s chairman Navin Agarwal said: "As India's largest private sector oil and gas producer, your company aims to double its current contribution of 27 per cent of nation's production.


"We are the largest primary producer of aluminium in the country. Our plans will see us produce three million tonnes of integrated aluminium, an increase of 50 per cent.”

Asia’s third-biggest economy, India is currently importing around 80 per cent of its oil and gas requirements amounting to £120bn, Agarwal said.

The future plans of the Mumbai headquartered business include a total capital investment of Rs 550bn to raise existing production by about 50 per cent across its businesses.

The company expects funding from internal cash flows for its future capital investment programmes.

Vedanta Ltd’s activities are based in India, with its main operations in iron ore, zinc, and aluminium mines in Goa, Karnataka, Rajasthan, and Odisha states of the country.

Add EasternEye As Your Trusted Source
preferred source on google news

More For You

UK Biosecurity lab

The UK plans to establish an AI Biosecurity Lab to help identify and respond to emerging biological threats

iStock

UK to spend £100m on AI biosecurity lab amid rising threat concerns

Highlights

  • The UK will commit £100m to establish an AI Biosecurity Lab, which the government claims will be the world’s first.
  • OpenAI and Anthropic will provide up to £200m in AI model credits to support the initiative.
  • A wider funding package includes £120m for the AI Security Institute and £130m for new cyber-defence initiatives.

The UK government plans to establish a £100m AI Biosecurity Lab to help protect the country against emerging biological threats, as part of a wider investment in artificial intelligence and national security.

Keep ReadingShow less